.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Novartis
Federal Trade Commission
Teva
US Army
Healthtrust
Covington
McKesson
Deloitte

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077170

« Back to Dashboard
NDA 077170 describes CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, which is a drug marketed by Sun Pharm Inds Ltd, Ivax Sub Teva Pharms, and Sandoz, and is included in three NDAs. It is available from thirty-two suppliers. Additional details are available on the CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE profile page.

The generic ingredient in CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.

Summary for NDA: 077170

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 077170

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
cetirizine hydrochloride; pseudoephedrine hydrochloride
 TABLET, EXTENDED RELEASE;ORAL 077170 ANDA L Perrigo Company 0113-0176 0113-0176-53 2 BLISTER PACK in 1 CARTON (0113-0176-53) > 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
cetirizine hydrochloride; pseudoephedrine hydrochloride
 TABLET, EXTENDED RELEASE;ORAL 077170 ANDA L Perrigo Company 0113-0176 0113-0176-62 4 BLISTER PACK in 1 CARTON (0113-0176-62) > 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength5MG;120MG
Approval Date:Feb 25, 2008TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
AstraZeneca
QuintilesIMS
Mallinckrodt
Farmers Insurance
Express Scripts
Queensland Health
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot